• OSR Holdings posted a wider operating loss of USD 3.67 million for the quarter ended March 31, 2026, up 26%, as net sales fell 36% to USD 484,057.
• Gross profit slipped 5% to USD 160,281, while gross margin rose 11 percentage points to 33% on a shift at RMC from purchase-and-resale to a consignment-based arrangement that recognizes commission revenue.
• Selling, general and administrative expenses increased 24% to USD 3.83 million, driven by higher personnel-related costs and professional service fees tied to public company obligations.
• Loss before income taxes narrowed 66% to USD 3.92 million as other expense improved to USD 252,305 from merger-related costs recognized in the prior-year quarter.
• Subsequent to quarter-end, Vaximm and BCME signed a global exclusive VXM01 license with up to about USD 815 million in potential milestones, while OSR also issued a senior secured convertible promissory note with principal of USD 1,055,555.55 for USD 500,000 in cash and a reduction of about USD 2 million in warrant obligations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OSR Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-055492), on May 13, 2026, and is solely responsible for the information contained therein.